Tune Therapeutics

GC Therapeutics

This deep-tech company develops a cell programming platform to produce off-the-shelf medicines for patients with gastrointestinal, neurological and immunological diseases.

Rewrite Therapeutics

This deep-tech company develops DNA writing and genome editing tools for biotechnology firms to treat genetic diseases.

Type6 Therapeutics

This deep-tech company develops kinase inhibitors for cancer treatment, intercepting enzymes in their inactive states to address drug resistance for patients with aggressive tumours.

Engimmune Therapeutics

This deep-tech company develops soluble T-cell receptor drugs for healthcare providers to treat patients with solid tumour cancers and immune-mediated diseases.

SymphoRNA

This deep-tech company develops multi-RNA combination medicines to treat complex diseases such as fibrosis and heart failure for the pharmaceutical and healthcare sectors.

Epicrispr

This company develops epigenomic therapies to control gene expression in patients with complex diseases.

Kodikaz Therapeutic Solutions

This deep-tech company develops a non-viral delivery platform for cell-specific gene therapies to treat cancer patients.

Epitome Therapeutics

This biotechnology firm develops an epigenome editing platform for programmable gene expression to treat patients with rare genetic and metabolic disorders.